Detalhe da pesquisa
1.
New target therapies in prostate cancer: from radioligand therapy, to PARP-inhibitors and immunotherapy.
Q J Nucl Med Mol Imaging
; 68(2): 101-115, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38860274
2.
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial.
Lancet Oncol
; 23(10): 1287-1296, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36096156
3.
Resound Trial: A phase 2 study of regorafenib in patients with thymoma (type B2-B3) and thymic carcinoma previously treated with chemotherapy.
Cancer
; 128(4): 719-726, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34706060
4.
Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma.
J Urol
; 193(6): 1905-10, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25433306
5.
Autoimmunity in thymic epithelial tumors: a not yet clarified pathologic paradigm associated with several unmet clinical needs.
Front Immunol
; 15: 1288045, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38629065
6.
Rituximab in steroid-refractory immune-related pancreatitis: a case report.
Front Oncol
; 13: 1205720, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37588091
7.
Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: Work still in progress.
Front Immunol
; 14: 1121557, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36776840
8.
Thymic Epithelial Tumor and Immune System: The Role of Immunotherapy.
Cancers (Basel)
; 15(23)2023 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38067278
9.
Advances in drug treatments for mesothelioma.
Expert Opin Pharmacother
; 23(8): 929-946, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35508368
10.
Oligoprogressive castration-resistant prostate cancer treated with metastases-directed stereotactic body radiation therapy: predictive factors for patients' selection.
Clin Exp Metastasis
; 39(3): 449-457, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35190933
11.
Systemic treatments for thymic tumors: a narrative review.
Mediastinum
; 5: 24, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35118329
12.
Case report of acute aortic dissection during treatment with capecitabine for a late recurrence of breast cancer.
Chemotherapy
; 56(3): 203-7, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20551636
13.
Current Perspectives on Immunotherapy in the Peri-Operative Setting of Muscle-Infiltrating Bladder Cancer.
Front Oncol
; 10: 568279, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33194654
14.
A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma.
Lung Cancer
; 142: 132-137, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32102735
15.
Pulmonary sarcomatoid carcinoma presenting both ALK rearrangement and PD-L1 high positivity: A case report on the therapeutic regimen.
Medicine (Baltimore)
; 98(32): e16754, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31393391
16.
Gene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient's follow-up.
Lung Cancer
; 59(3): 369-76, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17920725
17.
Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy.
J Clin Oncol
; 36(4): 342-349, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29240542
18.
Assessment of tumor response in malignant pleural mesothelioma.
Cancer Treat Rev
; 33(6): 533-41, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17764849
19.
Prognostic and predictive role of [18 F]fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up-front pemetrexed-based chemotherapy.
Cancer Med
; 6(10): 2287-2296, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28941158
20.
Short schedule of cisplatin and vinorelbine: a dose-finding study in non-small-cell lung cancer.
Oncology
; 71(3-4): 229-36, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17652944